Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint. - Tsao HW; Anderson S; Finn KJ; Perera JJ; Pass LF; Schneider EM; Jiang A; Fetterman R; Chuong CL; Kozuma K; Stickler MM; Creixell M; et al. (Immunity, 2024)